FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

385114002: Prolonged-release transdermal patch (dose form)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3634738017 Prolonged-release transdermal patch (dose form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3634739013 Prolonged-release transdermal patch en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1878731000052117 depåplåster sv Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Sweden NRC maintained module (core metadata concept)

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Prolonged-release transdermal patch (dose form) Is a kutan och/eller transdermal läkemedelsform false Inferred relationship Some
Prolonged-release transdermal patch (dose form) Is a läkemedelsplåster false Inferred relationship Some
Prolonged-release transdermal patch (dose form) Has dose form intended site (attribute) Transdermal (intended site) true Inferred relationship Some
Prolonged-release transdermal patch (dose form) Is a Transdermal dose form (dose form) true Inferred relationship Some
Prolonged-release transdermal patch (dose form) Has dose form administration method (attribute) Apply (administration method) true Inferred relationship Some
Prolonged-release transdermal patch (dose form) Has dose form transformation (attribute) No transformation true Inferred relationship Some
Prolonged-release transdermal patch (dose form) Has dose form release characteristic (attribute) Prolonged-release (release characteristic) true Inferred relationship Some
Prolonged-release transdermal patch (dose form) Has basic dose form (attribute) Patch (basic dose form) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
kapsaicin 179 mg/timme, depåplåster Has manufactured dose form False Prolonged-release transdermal patch (dose form) Inferred relationship Some
Buprenorphine 20 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Buprenorphine 10 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
buprenorfin 5 mikrogram per timme, depåplåster Has manufactured dose form False Prolonged-release transdermal patch (dose form) Inferred relationship Some
nikotin 11 mg/24 timmar, depåplåster Has manufactured dose form False Prolonged-release transdermal patch (dose form) Inferred relationship Some
nikotin 22 mg/dygn, depåplåster Has manufactured dose form False Prolonged-release transdermal patch (dose form) Inferred relationship Some
Glyceryl trinitrate 800 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely glyceryl trinitrate 200 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely glyceryl trinitrate 400 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely glyceryl trinitrate 600 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
estradiol 0,025 mg/dag, plåster Has manufactured dose form False Prolonged-release transdermal patch (dose form) Inferred relationship Some
estradiol 0,375 mg/dag, plåster Has manufactured dose form False Prolonged-release transdermal patch (dose form) Inferred relationship Some
estradiol 0,05 mg/dag, plåster Has manufactured dose form False Prolonged-release transdermal patch (dose form) Inferred relationship Some
estradiol 0,075 mg/dag, plåster Has manufactured dose form False Prolonged-release transdermal patch (dose form) Inferred relationship Some
estradiol 0,1 mg/dag, plåster Has manufactured dose form False Prolonged-release transdermal patch (dose form) Inferred relationship Some
skopolamin 0,5 mg/24 timmar, plåster Has manufactured dose form False Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely glyceryl trinitrate 300 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
estradiol 0,05 mg + noretindronacetat 0,14 mg/dag, depåplåster Has manufactured dose form False Prolonged-release transdermal patch (dose form) Inferred relationship Some
estradiol 0,05 mg + noretindronacetat 0,25 mg/dag, depåplåster Has manufactured dose form False Prolonged-release transdermal patch (dose form) Inferred relationship Some
estradiol 14 mikrogram/dag, depåplåster Has manufactured dose form False Prolonged-release transdermal patch (dose form) Inferred relationship Some
etinylestradiol 0,02 mg + norelgestromin 0,15 mg per dygn, depåplåster Has manufactured dose form False Prolonged-release transdermal patch (dose form) Inferred relationship Some
Fentanyl 12 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
selegilin 6 mg/24 timmar, depåplåster Has manufactured dose form False Prolonged-release transdermal patch (dose form) Inferred relationship Some
selegilin 9 mg/24 timmar, depåplåster Has manufactured dose form False Prolonged-release transdermal patch (dose form) Inferred relationship Some
selegilin 12 mg/24 timmar, depåplåster Has manufactured dose form False Prolonged-release transdermal patch (dose form) Inferred relationship Some
rivastigmin 4,6 mg/24 timmar, depåplåster Has manufactured dose form False Prolonged-release transdermal patch (dose form) Inferred relationship Some
rivastigmin 9,5 mg/24 timmar, depåplåster Has manufactured dose form False Prolonged-release transdermal patch (dose form) Inferred relationship Some
estradiol 0,06 mg/dag, depåplåster Has manufactured dose form False Prolonged-release transdermal patch (dose form) Inferred relationship Some
Estradiol 2.083 microgram/hour and norethisterone acetate 10.417 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Estradiol 3.125 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Estradiol 1.042 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Estradiol 1.563 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely estradiol 1.667 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Rotigotine 83.333 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely estradiol 2.083 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Estradiol 2.083 microgram/hour and norethindrone acetate 7.083 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely estradiol 3.333 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely estradiol 4.167 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Hyoscine 13.889 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely fentanyl 25 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Testosterone 104.167 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Buprenorphine 35 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely fentanyl 50 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely buprenorphine 52.5 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely buprenorphine 70 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely fentanyl 75 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely fentanyl 100 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely granisetron 129.167 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Rotigotine 166.667 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Glyceryl trinitrate 208.333 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Testosterone 208.333 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely testosterone 250 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Nicotine 291.667 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely nicotine 312.5 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely glyceryl trinitrate 416.667 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Nicotine 583.333 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Glyceryl trinitrate 625 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Nicotine 625 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely rotigotine 250 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely nicotine 875 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely nicotine 937.5 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely estradiol 2.08 microgram/1 hour and norethisterone acetate 10.4 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Estradiol 1.04 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Estradiol 1.56 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Estradiol 1.88 microgram/hour and levonorgestrel 625 nanogram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Estradiol 2.5 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely estradiol 2.08 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Ethinylestradiol 1.46 microgram/hour and norelgestromin 6.25 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Estradiol 3.13 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
estradiol 4,17 mikrogram/timme, depåplåster Has manufactured dose form False Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely selegiline 250 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Estradiol 2.08 microgram/hour and norethisterone acetate 5.83 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Estradiol 583 nanogram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Selegiline 500 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely oxybutynin 162 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Selegiline 375 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely nicotine 917 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Nicotine 458 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Rivastigmine 192 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Rivastigmine 396 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some

Reference Sets

GB English

US English

Back to Start